
Jana Hersch, Forbes Councils Member
· 1 min read
AI Raises The Stakes For Discovery Data
Jana Hersch, Head of Corporate Scientific Research at Genedata.
Historically, pharmaceutical organizations treated early discovery research and later regulated development as separate worlds. That distinction is becoming harder to maintain as AI models learn from discovery data and increasingly inform candidate selection, developability assessments, manufacturability predictions and other decisions that guide a molecule’s path through development. New regulations are also emerging around how AI is governed, documented and traced.
These shifts make high-quality discovery data matter far more than it once did. That increased value also brings a new risk: validation debt, a hidden liability that accumulates when scientific data and AI models lack the documentation and traceability needed for future use in good practice (GxP) environments, where requirements for data integrity, traceability, auditability and validation apply. The longer this debt accumulates, the harder and more costly it becomes to address.
Where Discovery Ends And GxP Begins
GxP standards come into play as candidates enter regulated safety testing, clinical development and manufacturing phases. Discovery research, by contrast, sits outside this framework. The boundary was once treated as clear: research generated knowledge, while development generated regulated evidence.
Discovery data can inform development decisions and, when properly contextualized and traceable, support downstream regulatory activities. Creating that flow requires data integrity and traceability in discovery, rather than retrofits at the GxP boundary, so research data remains interpretable and defensible as it moves downstream.
As AI models increasingly connect discovery data, scientific decisions and development outcomes, discovery data is increasingly subject to questions that most legacy electronic lab notebooks (ELNs) and other documentation systems were never designed to answer.
The Demands Of Data Integrity
6. Is it traceable?
Original source
This story was published by Forbes: Innovation and written by Jana Hersch, Forbes Councils Member. SyncAI.news shows a preview; the complete article is on the publisher's site.
Read the full story on forbes.com


